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Methylomic Aging as a Window onto the Influence of Lifestyle: Tobacco
and Alcohol Use Alter the Rate of Biological Aging
Abstract
Objectives—To examine the effect of the relationship between alcohol and cigarette consumption on
biological aging using deoxyribonucleic acid (DNA) methylation-based indices.
Design—We examined the association between DNA methylation indices of smoking and alcohol to those
for biological aging in two independent cohorts using the epigenetic “clock” provided by Hannum and
colleagues.
Setting—Longitudinal studies of aging and the effect of psychosocial stress.
Participants—Publicly available genome-wide methylation data from participants in two ethnically
informative cohorts (n=656 white, n=180 black).
Measurements—Deviation of biological age from chronological age as a result of smoking and alcohol
consumption.
Results—Greater cigarette consumption was associated with accelerated biological aging, with strong effects
evident at even low levels of exposure. In contrast, alcohol consumption was associated with a mixed effect on
biological aging and pronounced nonlinear effects. At low and heavy levels of alcohol consumption, there was
accelerated biological aging, whereas at intermediate levels of consumption there was a relative decelerating
effect. The decelerating effects of alcohol were particularly notable at loci for which methylation increased
with age.
Conclusion—These data support prior epidemiological studies indicating that moderate alcohol use is
associated with healthy aging, but we urge caution in interpreting these results. Conversely, smoking has
strong negative effects at all levels of consumption. These results also support the use of methylomic indices as
a tool for assessing the impact of lifestyle on aging.
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Abstract
Objectives—To examine the effect of the relationship between alcohol and cigarette 
consumption on biological aging using deoxyribonucleic acid (DNA) methylation-based indices.
Design—We examined the association between DNA methylation indices of smoking and 
alcohol to those for biological aging in two independent cohorts using the epigenetic “clock” 
provided by Hannum and colleagues.
Setting—Longitudinal studies of aging and the effect of psychosocial stress.
Participants—Publicly available genome-wide methylation data from participants in two 
ethnically informative cohorts (n=656 white, n=180 black).
Measurements—Deviation of biological age from chronological age as a result of smoking and 
alcohol consumption.
Results—Greater cigarette consumption was associated with accelerated biological aging, with 
strong effects evident at even low levels of exposure. In contrast, alcohol consumption was 
Corresponding author: Robert A. Philibert, Department of Psychiatry, Rm 2–126 MEB, 500 Newton Road, Iowa City, IA, 52242. 
robert-philibert@uiowa.edu. 
Drs. Beach and Philibert had full access to all of the data in the study and take responsibility for the integrity of the data and the 
accuracy of the data analysis.
Conflict of Interest: Pending property claims cover the use of DNA methylation to assess alcohol use status. U.S. patent 8,637,652 and 
other pending claims cover the use of DNA methylation to assess smoking status. Dr. Philibert is a potential royalty recipient on those 
intellectual right claims. Dr. Philibert is an officer and stockholder of Behavioral Diagnostics (www.bdmethylation.com).
Author Contributions: All authors contributed to this paper.
Sponsor’s Role: None
HHS Public Access
Author manuscript
J Am Geriatr Soc. Author manuscript; available in PMC 2016 December 01.
Published in final edited form as:
J Am Geriatr Soc. 2015 December ; 63(12): 2519–2525. doi:10.1111/jgs.13830.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
associated with a mixed effect on biological aging and pronounced nonlinear effects. At low and 
heavy levels of alcohol consumption, there was accelerated biological aging, whereas at 
intermediate levels of consumption there was a relative decelerating effect. The decelerating 
effects of alcohol were particularly notable at loci for which methylation increased with age.
Conclusion—These data support prior epidemiological studies indicating that moderate alcohol 
use is associated with healthy aging, but we urge caution in interpreting these results. Conversely, 
smoking has strong negative effects at all levels of consumption. These results also support the use 
of methylomic indices as a tool for assessing the impact of lifestyle on aging.
The shifting age of the world’s population suggests a greater need for indices of healthy 
aging that can provide empirical grounding for medical advice on the likely effect of 
lifestyle change. (1) As first reviewed by Fraga and Esteller in 2007 and more recently by 
Hannum and colleagues in 2013, recent work on epigenetic correlates of chronological aging 
has provided a new approach to examination of the effects of environmental factors on 
aging. (2–5)
Hannum and colleagues developed an index of aging referred to as apparent methylomic 
aging rate, which is defined as the ratio of predicted age, based on methylation data, to 
chronological age.(2) For those interested in using blood-based assessments of the effect of 
lifestyle or environmental factors on aging, this type of epigenetic clock, or index of 
methylomic age,(6) provides several advantages, including strong correlation with 
chronological age (coefficient of determination > 0.95), constancy across the adult age 
range, lack of influence of sex, usefulness in a variety of tissue types, and ease of assessment 
through the use of a commonly used assessment platform (HumanMethylation450 Beadchip, 
Illumina, San Diego, CA). (2)
There also has been substantial progress in the use of deoxyribonucleic acid (DNA) 
methylation to quantify cigarette consumption. Over the past several years, it has been 
demonstrated that smoking is associated with genome-wide changes in DNA methylation.
(7–15) The most reliably and robustly differentially methylated CpG residue is referred to as 
cg05575921, which is found in the aryl hydrocarbon receptor repressor.(7) Since its initial 
association with smoking in 2012, eight consecutive genome wide analyses have shown that 
it is consistently the most robustly differentially methylated residue in the genome in 
response to smoking in all age groups. (7–15) Demethylation at cg05575921 is strongly 
associated with serum cotinine levels and daily cigarette consumption. (9)
A recent demonstration that a broad, dose-dependent pattern of altered methylation, 
particularly at a CpG residue found in a chromosome 10 open reading frame (C10orf35, 
a.k.a. cg23193759), is associated with alcohol consumption has complemented methylation 
findings with respect to cigarette consumption.(16) Taken together, these new DNA 
methylation assessment techniques address the well-known shortcomings of unreliable self-
reports of tobacco and alcohol consumption and provide an alternative method of 
determining the relationship between common types of substance use and critical healthcare 
outcomes(17), associations that are of great significance given that tobacco and alcohol use 
are, respectively, the first- and third-leading causes of preventable morbidity and mortality in 
the United States.(18–20)
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Improving upon the reliability of self-reported substance use is important.(21–23) Similarly, 
although well-structured assessments of alcohol consumption in the general population are 
thought to be adequately reliable, individuals at the highest risk of alcoholism have a high 
rate of nonparticipation in self-report surveys, and when they participate in these surveys, 
their self-report is often unreliable.(24) Accordingly, use of epigenetic biomarkers of 
substance use exposure may usefully supplement datasets of self-reported substance use and 
expand the number of usable data sets by allowing examination of substance use effects in 
data sets that do not include self-reported use.
These newly developed epigenetic approaches were used to quantify the effect of substance 
use on Hannum and colleagues “biological clock” and methylation at each of the 71 loci that 
comprise the clock using two independent, ethnically informative cohorts.
METHODS
Methylation at the 73 (71 for the clock, 1 each for smoking and alcohol consumption) CpG 
residues analyzed in this study were obtained from publically available Illumina 
HumanMethylation450 Beadchip datasets. The first set of methylation data (n=656; Gene 
Expression Omnibus (GEO) accession GSE40279) is from a study of the effects of aging on 
genome methylation by Hannum and colleagues. (2) The second set of human methylation 
data are from the Family and Community Health Studies (FACHS) (n=180; GEO accession 
numbers GSE35059 and GSE59550).(9) Their local institutional review boards approved the 
procedures and protocols used in each of those studies.
Analytical Approach
The association between smoking and drinking biomarkers and the biological clock was first 
examined in Hannum’s dataset. The averaged value of the 71 weighted indicators was used 
as the dependent variable, providing an index of relative biological age. Given the 
expectation of nonlinear effects, a hierarchical linear regression approach was used to 
examine linear and nonlinear effects of alcohol and cigarette smoke exposure sequentially, 
controlling for chronological age at each step. Accordingly, all observed effects represent 
effect on biological age net of chronological age. All analyses were conducted using Stata 
version 13.0 (StataCorp, College Station, TX). Discrepancies between biological and 
chronological age, in the form of residuals, were created using a regression procedure in 
which biological clock was the outcome, and chronological age was the independent 
variable. The residual has a mean of 0 and thus represents positive and negative deviations 
from chronological age in years. Using the index of discrepancy between biological and 
chronological age as the dependent variable, in step 1, the linear effect of the biomarker on 
discrepancy score was examined; in the second step, quadratic effects in the model were 
included. Cubic effects were also included in the final step. To identify the best-fitting model 
and so determine the presence of nonlinear effects, the fit of the nested models was 
contrasted using an F-test. Because the Hannum approach is robust with respect to blood cell 
composition and unaffected by sex(2) and Hannum and colleagues first cleaned then 
depleted the data set of all loci influence of sex before depositing their data, further data 
cleaning and controlling for sex for the 73 loci that were extracted were not attempted.
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To follow up and allow direct comparison with the replication sample, the association 
between the biomarkers for smoking and drinking and each of the loci included in the 
biological clock were also examined, controlling for chronological age. For ease of 
examination, clock loci were ordered so that all loci whose methylation values increased 
with age were in the upper half of Table 1, and those that decreased with age were in the 
bottom half of Table 1. Biomarker beta values decreased with greater substance use, so 
positive coefficients in the upper half of Table 1 indicate that greater consumption is 
associated with decelerated aging at a particular clock locus (with the significant values 
being shadowed). Negative correlations indicated accelerated aging (with the significant 
values being bolded). Conversely, in the bottom half of Table 1, positive coefficients indicate 
accelerated aging (with the significant values being bolded) whereas negative correlations 
indicated decelerated aging (with the significant values being shadowed).
To replicate and examine generalizability of linear effects for smoking, the analyses were 
repeated in a smaller sample of black adults selected to be smokers or nonsmokers. Because 
of missing intermediate levels, curvilinear effects on the overall index could not be 
examined. Accordingly, the sample was used to replicate the effect of biomarkers for 
smoking and drinking on the individual clock loci. Using the same format as for the Hannum 
dataset, the association between the biomarkers for smoking and drinking and each of the 
loci included in the biological clock were examined, controlling for chronological age.
RESULTS
The demographic characteristics of both of the cohorts examined are given in Table 2. The 
first cohort from Hannum and colleagues consisted of 656 white subjects with an average 
age of 63.4±14.8. No information on sex was available for the dataset. The second cohort 
consisted of 180 African Americans drawn from the Family and Community Health Studies 
(FACHS) with an average age of 48.9±8.6.
Examination of the Hannum and colleagues cohort
As a first step in the analyses, the simple correlation of each of the 71 “clock” loci with 
chronological age was computed, replicating the observation of Hannum regarding the 
robust association for each. As Table 1 indicates, each of the residues was significantly 
associated with chronological aging (p<.001). To address the primary study hypotheses, an 
index of the discrepancy between biological and chronological age was created by 
regressing chronological age on biological age and using the residual as the dependent 
variable. Using this dependent variable, the relationship between the previously derived 
quantitative measures of smoking and alcohol consumption and discrepancy scores was 
examined.
Because of the expectation of nonlinear effects, linear, quadratic, and cubic effects were 
stepped in, and the best fitting model was identified using direct contrasts of nested models. 
All hierarchal regression models were constructed using Stata version 13 (Stata Corp.). 
Smoking and drinking were quantified using methylation status at cg05575921 and 
cg23193759, respectfully, with methylation at each decreasing in response to greater 
consumption.
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In the analysis of the effect of smoking, stepping in the linear effect indicated that linear 
acceleration of the biological clock produced by exposure to cigarette smoke was significant 
(unstandardized beta = −8.730, p < .001), as was the quadratic term (unstandardized beta = 
−39.443, p = .049). Direct comparison of linear, quadratic, and cubic models using nested 
model comparisons confirmed that the quadratic model provided the best fit to the data. It 
significantly improved fit over the linear model (linear vs quadratic: F(1, 653) = 3.89, p = .
049), and there was no additional significant improvement when a cubic component was 
added (quadratic vs cubic: F(1, 652) = 0.88, p = .35). Accordingly, the effect of smoking on 
overall biological aging was asymptotic, with the effect of increasing smoke exposure on 
accelerated aging greater as participants moved from no exposure to moderate smoke 
exposure, and with effect on biological aging leveling off at higher levels of smoking 
exposure (Figure 1).
The association between cg23193759 and an index of discrepancy between biological and 
chronological age was similarly examined. Again, the best-fitting model was found to be one 
that contained a nonlinear component. Although linear and quadratic effects of alcohol 
consumption on discrepancy score were nonsignificant before the cubic component was 
entered, they were significant in the final model that included cubic effects, with results 
suggesting that the cubic component of the model qualified the linear decelerating effect of 
alcohol consumption on biological age (unstandardized beta = −186.8059, p = .01) and the 
quadratic effect (unstandardized beta = 796.201, p = .02). The significant cubic component 
(unstandardized beta = −969.066, p = .03) highlighted the reversal of effects at the extremes. 
Very low and very high levels of alcohol consumption as measured by cg23193759 were 
associated with faster biological aging relative than moderate consumption. Direct 
comparison of linear, quadratic, and cubic models using nested models indicated that the 
cubic model provided the best fit to the data (linear vs cubic: F(2, 652) = 3.65, p = .03) and 
(quadratic vs cubic: F(1,652) = 4.51, p = .03). Accordingly, the pattern of results indicates 
that the relatively decelerating effect of alcohol consumption on aging is present only for 
variation in the moderate range of consumption (Figure 1).
Simple linear associations at each of the 71 residues were also examined to better 
characterize the pattern of effects of smoking and drinking. Controlling for chronological 
age, methylation status at 33 of the 71 CpG residues was significantly associated with 
methylation status at cg05575921 (smoking), whereas methylation status at 55 loci was 
associated with methylation at cg23193759 (alcohol consumption). Only 11 loci were not 
associated with cg05575921 or cg23193759, indicating that substance use affected a 
substantial majority of the clock loci.
The effect of smoking and drinking on the individual loci that constitute the biological clock 
were different for those epigenetic indicators that increased with age from those that 
decreased with age. Focusing on clock indicators at which methylation increases with 
chronological age (those in the top half of Table 1) showed that smoking exposure was 
associated with little effect. Three indicators showed significant decelerating effects, 
indicated by shadowed coefficients, whereas as two showed accelerating effects, indicated 
by bolded coefficients. Conversely, for loci at which methylation decreases with increasing 
chronological age (those in the bottom half of Table 1), it can be seen that smoking exposure 
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is consistently associated with accelerated aging. That is, 28 indicators (bolded) showed an 
accelerating effect on aging, whereas none showed a decelerating effect. For alcohol 
exposure, the patterning of effects was different. The indicators in the top half of Table 1 
(those that increase with age) showed consistent effects of alcohol exposure in the direction 
of decelerating biological aging, with 27 indicators (shadowed) showing significant 
deceleration and only three showing significant acceleration (bolded) in response to greater 
alcohol exposure. For indicators in the bottom half of Table 1, the effect of alcohol exposure 
is robustly in the direction of acceleration of aging, with 25 indicators (bolded) showing 
significant acceleration and none showing deceleration. Accordingly, the bulk of the effect 
for alcohol and smoking exposure on biological aging is attributable to their acceleration of 
ongoing demethylation or slowing of ongoing hypermethylation (i.e., they are associated 
with decreased methylation).
Replication Using the FACHS cohort
Because the Hannum data were derived from samples of individuals of European ancestry, 
the analyses were repeated using data from 180 subjects from the FACHS selected to be 
smokers or nonsmokers. The FACHS sample is a longitudinal sample assessing health 
behaviors in black individuals across a range of sociodemographic circumstances. From this 
sample, 85 self-reported smokers and 95 nonsmokers whose methylation was examined 
using the Illumina array platform were randomly selected. Using this sample, the 
relationship between the biological clock and chronological age was replicated (coefficient 
of determination (r) = 0.775, p < .001), and the relative strength of the 71 regression 
coefficients linking methylation to chronological age across the two samples was replicated 
(r = 0.961).
All the proposed epigenetic clock indicators were associated with aging in the same 
direction as in the Hannum and colleagues’ data set. (See Appendix 1 for table of effects in 
the replication sample.) Only linear contrasts were examined. Methylation status at 31 clock 
residues was significantly associated with methylation status at cg05575921 (smoking), and 
37 residues were significantly associated at cg23193759 (alcohol consumption). For 
smoking effects, 20 were direct replications of significant associations identified in the 
Hannum data set (64.5%). For drinking effects, 34 were direct replications of significant 
associations identified in the Hannum data set (91.9%). Similar patterns of effects were 
observed within subsets of loci as well. For loci at which methylation increased with 
chronological age, tobacco use was inconsistently associated with biological age (6 
accelerating, 4 decelerating). Conversely, for loci at which methylation decreased with 
chronological age, tobacco use was consistently associated with accelerated aging (21 
accelerating, 0 decelerating) (p<.001)). Likewise, for indicators that increased with age, 
alcohol use was robustly associated with decelerated aging (23 decelerating, 0 accelerating), 
but for indicators that decreased with chronological age, alcohol consumption was 
associated with accelerated aging (14 accelerating, 0 decelerating) (p<.001).
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DISCUSSION
Using a recently developed index of biological aging, support was found for a previously 
hypothesized effect of smoking on accelerated aging and a previously hypothesized 
curvilinear effect of alcohol consumption on aging. Effects showing that the epigenetic clock 
developed using data from white subjects generalized to a black sample were replicated, and 
similar patterns of effects of smoking and drinking on the individual loci comprising the 
clock were found in both samples. Examination of nonlinear effects indicated a significant 
quadratic effect for cigarette smoke exposure, reflecting an asymptotic impact, whereas 
alcohol consumption showed a significant cubic effect, suggesting an advantage of moderate 
levels of consumption. Unexpectedly, both data sets indicated divergent patterns of effect 
among epigenetic clock indicators depending on whether the indicators increased or 
decreased with age. Epigenetic clock indicators that increased with chronological age were 
most useful in identifying the divergent effects of alcohol and tobacco on biological aging, 
with alcohol producing robust decelerating effects but smoking having inconsistent effects 
for these indicators. Conversely, epigenetic clock indicators that decreased with age were 
most useful in identifying the shared effects of alcohol and tobacco on accelerating aging, 
with cigarette smoke and alcohol consumption producing accelerating effects on the aging 
indicators.
These results suggest that, despite being correlated, the effects of alcohol and smoking 
consumption on biological aging are different. Whereas smoking accelerated biological 
aging at any level of consumption, alcohol had a more-complex association with aging. 
When examining the 40 loci at which greater methylation was associated with older 
chronological age, significant antiaging effects of alcohol were found in both data sets at 19 
loci. In contrast, when examining the 41 loci at which lower methylation was associated 
with greater chronological aging, no replicable protective effects of alcohol were noted. 
Second, consistent with prior epidemiological examinations, moderate alcohol consumption 
was associated with decelerated aging overall.(25, 26) The U-shaped curve found in the 
current study is similar to that found with respect to the effects of alcohol consumption on 
other health-related outcomes, including quality of life and bone density.(27, 28)
These data are silent as to the mechanism of the benevolent association between moderate 
alcohol intake and slower aging. One controversial viewpoint is that substances, such as 
resveratrol, found in certain alcoholic beverages (e.g., red wine) directly moderate the 
beneficial effects of alcohol,(29) but some of the subsequent basic and clinical studies have 
been less confirmatory. (30–33) Also, because abstainers often do so because of chronic 
severe medical disorders or prior difficulties with substances, this could account for some of 
the effect with respect to aging at the lower range of alcohol consumption. The beneficial 
effects attributed to moderate alcohol consumption observed here and elsewhere may be 
largely secondary to healthy behavioral habits found in those who drink moderately. 
Interrogation of epidemiologically sound, behaviorally informed cohorts that also have DNA 
for epigenetic testing may answer more effectively whether it is the moderate alcohol 
consumption or the accompanying behavioral habits that are responsible for the observed U-
shaped curve.
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In contrast, no significant protective effects of smoking for aging were found in either 
dataset at any of the loci. Increasing cigarette consumption as indicated by cg05575921 was 
reproducibly associated with methylation status at 20 of the 71 epigenetic clock indicators, 
with marked enrichment at loci at which methylation is negatively associated with aging. 
Because prior studies have shown that heavy chronic smoking itself has nominally 
significant effects on methylation status at nearly one-quarter of the CpG loci in the genome, 
the number of significantly affected loci found in the current study is not surprising.(9) 
Furthermore, given the prominent effects of smoking on methylation at genes involved in 
inflammation(7, 9, 34) and the strong inflammatory components of many forms of common 
complex illness, including diabetes mellitus, coronary artery disease, and obesity(35–37), 
the hypothesis that inflammation mediates the effects of smoking on aging should be 
examined.
Black and white individuals had similar patterns of effect on individual clock indicators for 
the biomarkers of smoking (cg05575921) and alcohol consumption (cg23193759). Although 
requiring additional replication, this finding suggests that effects of substances on biological 
aging may be generalizable across social and demographic categories and specifically that 
results using the biological clock may be generalizable across black and white samples.
Several other groups have described epigenetic clocks based on methylation data.(38, 39) 
The 353 probes identified in one study(38) and the three in the other(39) use data only from 
probes from the Illumina 27k array that were also present in the Illumina 450k array. 
Because Hannum’s marker set was designed specifically for use in blood-derived DNA, and 
all of the current study data are based on the 450K array, which is less promoter-centric than 
the 27k array, the use of the Hannum clock allows for a less-biased assessment of aging in a 
marker set designed specifically for the tissue and the platform used in the methylation 
assessments. Still, it is unlikely that this array will be the final word in methylation 
assessments, and future studies using whole-genome approaches with methylation-
independent measures of substance consumption (e.g., cotinine levels) could markedly 
improve understanding of this important subject.
The current results highlight the potential for existing epidemiological datasets that have 
DNA to provide useful insights beyond those for which they were initially collected. In the 
area of substance use research, this potential seems considerable. Likewise, studies designed 
to examine the effect of other lifestyle choices and circumstances may be extended to 
examine effects on biological aging directly. The results also highlight a potential solution to 
the problem of substantial error in self-report approaches to assessment of substance use and 
suggest that epigenetic indicators of substance use may allow more-nuanced examination of 
effects on aging, such as examination of nonlinear associations.
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Figure 1. 
Graph of the best-fitting model representing the effect of smoking consumption (solid line; 
cg05575921) and alcohol consumption (dotted line; cg23193759) on biological aging using 
Hannum’s weights. All values within ±3 standard deviations of the mean of each predictor 
are included. In each case, lower scores on the x-axis indicate greater substance use 
exposure, and higher scores on the y-axis indicate relatively greater acceleration of the 
biological clock. Predicted scores represent residual biological age after controlling for 
chronological age.
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Table 2
Demographic Characteristics of the Study Cohorts
Characteristic Hannum, N=656 Family and Community Health Studies, N=180
Age, mean±standard deviation (range) 63.4 ± 14.8 (19–101) 48.9 ± 8.6 (35–91)
Sex, n
 Male NA 79
 Female NA 111
Race and ethnicity, n
 White 482
 White Hispanic 174
 Black 180
NA=not available.
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